Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
https://www.newsnationnow.com/travel/tsa-problems-spring-break/...
http://humanevents.com/2026/03/14/uk-court-sentences-trans-identifying-male-to-9-years-for-rape-of-young-girls...
